Researchers recently conducted a 180 day trial of an implantable sensor for continuous glucose monitoring. Adult participants had a small incision cut into their upper arm where the sensor, a small cylinder less than half an inch long, was inserted. The incision was closed with sterile tape and a transmitter was worn in the arm where the sensor was inserted.
The results of the trial showed promise. The CGM caught 80% of participants’ low blood sugars. Only 10% reported discomfort with either insertion of the sensor or wearing the tube. And most liked the convenience of going three months between insertions. You can read more here.
This kind of technology is not a game changer by any means, but it does offer a step in the right direction–that being to make medical care for Type 1 as unobtrusive as possible.
Last year, I wrote about the insulin smart patch being developed by researchers at UNC. Stay tuned for an update on that soon!